Insights into human carboxylesterase 2 stability and activity in vivo and in vitro by Ferreira, Pedro Garcia
 Pedro Garcia Ferreira 
Degree in Pharmacy  
   
  
  
Insights into human carboxylesterase 2 
stability and activity in vivo and in vitro 
  
  
Dissertation to obtain a Master Degree in Biotechnology 
   
  
Supervisor: Ana Luisa Simplício, Ph. D, IBET/ITQB-UNL 
           
          
 
Júri: 
Presidente: Prof. Doutor Carlos Alberto Gomes Salgueiro 
Arguente: Prof. Doutor Pedro Miguel Ribeiro Viana Batista 
Vogal: Doutora Ana Luisa Simplício 
 
  
 
September 2012 
  
  
   
 Pedro Garcia Ferreira 
Degree in Pharmacy  
   
  
  
Insights into human carboxylesterase 2 
stability and activity in vivo and in vitro 
  
  
Dissertation to obtain a Master Degree in Biotechnology 
   
  
Supervisor: Ana Luisa Simplício, Ph. D, IBET/ITQB-UNL 
           
 
          
Júri: 
Presidente: Prof. Doutor Carlos Alberto Gomes Salgueiro 
Arguente: Prof. Doutor Pedro Miguel Ribeiro Viana Batista 
Vogal: Doutora Ana Luisa Simplício 
 
  
 
September 2012 
 
titulo da tese 
  
  
 “Insights into human carboxylesterase 2 stability and activity in vivo and in vitro” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright Pedro Garcia Ferreira, FCT/UNL, UNL 
 
                 
 
 
A Faculdade de Ciências e Tecnologia e a Universidade Nova de Lisboa têm o direito, perpétuo 
e sem limites geográficos, de arquivar e publicar esta dissertação através de exemplares 
impressos reproduzidos em papel ou de forma digital, ou por qualquer outro meio conhecido ou 
que venha a ser inventado, e de a divulgar através de repositórios científicos e de admitir a sua 
cópia e distribuição com objetivos educacionais ou de investigação, não comerciais, desde que 
seja dado crédito ao autor e editor. 
 
  
i 
 
Acknowledgments 
 
Em primeiro e principal lugar gostaria de agradecer à Dra. Ana Luisa Simplício, responsável 
pelo laboratório de Farmacocinética e Analise Biofarmacêutica, por uma vez mais me ter dado 
a oportunidade de levar a cabo um trabalho académico essencial para a minha formação, e 
principalmente pela grande disponibilidade para ajudar, dar conselhos ou mesmo motivação e 
incentivo para continuar o trabalho. 
 
Agradeço também à Joana Lamego e Bárbara Cunha, pelo tempo despendido a ajudar-me e a 
explicar tudo o que fosse necessário, e até pelas perguntas incisivas que fazem mesmo uma 
pessoa pensar! 
 
À equipa do laboratório de Nutracêuticos e Libertação Controlada, nomeadamente Dra. Teresa 
Serra, Sara Nunes, Joana Poejo e Ana Nunes, onde parte do trabalho foi realizado, agradeço 
também a grande disponibilidade, ajuda e sempre bom ambiente. 
 
Aos amigos ITQBianos André, Daniel, João e Rita pela companhia, momentos de 
descontracção e distração do trabalho. 
 
E à minha família e amigos, especialmente pais e irmão pela constante motivação para concluir 
o trabalho e por nunca duvidarem que os meus objectivos seriam atingidos. 
 
Agradeço também à Fundação para a Ciência e Tecnologia, Portugal (PTDC/EBB-
BIO/111530/2009, PEst-OE/EQB/LA0004/2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
iii 
 
Abstract 
 
 
Due to its role in ester containing xenobiotics metabolization, such as the activation of pro-
drugs, carboxylesterase 2 (CES2) has become an attractive enzyme, with potential applications 
in the field of chemotherapy. Still, it hasn’t been as thoroughly characterized as the other main 
human carboxylesterase, the carboxylesterase 1 (CES1), having no described structure yet. 
The original hypothesis being tested in this work was the possibility of enzyme-enzyme 
interaction that had been suggested from previous work in the host laboratory. 
The initial task of this project was therefore to further assess CES2 stability and to test possible 
enzyme-enzyme interaction with CES1, by characterizing enzyme hydrolytic kinetics in different 
assay conditions and evaluating the behaviour of enzyme mixtures. 
Different CES2 activity rates were observed when tested in different reaction conditions 
suggesting a stabilizing/destabilizing effect on the enzyme, but evidence of in vitro interactions 
was not confirmed.  
Considering the dependence of conclusions on test methods as well as the extreme care 
measures that have to be taken for avoiding enzyme degradation during the preparation of cell 
extracts, a second goal was envisaged for this project. This consisted in the development of a 
new method capable of determining CES activity in conditions closer to those that are found 
physiologically.  
A new spectrofluorometric method able to assess carboxylesterase activity in intact living cells, 
using loperamide as a specific CES2 inhibitor and Bis(4-nitrophenyl) phosphate as a total 
carboxylesterase inhibitor was therefore developed and applied to Caco-2, HT-29. Hep G2 and 
HEK-293T cell lines. 
The method proved itself capable of detecting CES total activity in living cells, as well as to 
differentiate between CES2 and other CES activities. Differences were shown between this and 
the traditional methods using cell extracts, suggesting that the latter may not be the best option 
when trying to predict in vivo CES behavior. 
 
Keywords: Carboxylesterase 2, enzymatic activity, enzymatic stability, whole living cells 
method 
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Resumo 
 
Devido ao seu papel na metabolização de xenobióticos, tal como a activação de pro-fármacos, 
a carboxylesterase 2 (CES2) tem vindo a ganhar interesse, com potenciais aplicações no 
campo da quimioterapia. No entanto ainda não foi tão extensivamente caracterizada como a 
outra principal carboxilesterase humana, a carboxylesterase 1 (CES1), não tendo ainda sido 
descrita a sua estrutura. 
A hipótese original a ser testada no projecto foi a possibilidade de uma interação enzima-
enzima, sugerida por um trabalho anterior realizado no laboratório. 
O objectivo deste projecto foi a caracterização da estabilidade da CES2 e testar uma possível 
interacção enzima-enzima com a CES1, através da caracterização dos parâmetros cinéticos de 
em diferentes condições e do comportamento de misturas de ambas as enzimas. 
Observaram-se diferentes taxas de actividade de CES2 quando testada em diferentes 
condições, sugerindo um efeito estabilizador/desestabilizador na enzima, mas não foi 
confirmada a evidência de uma interacção in vitro. 
Tendo em conta a dependência dos resultados nos respectivos métodos analíticos, assim 
como o cuidado extremo necessário para evitar a degradação enzimática durante a preparação 
de extractos celulares, surgiu um segundo objectivo para este projecto, consistindo no 
desenvolvimento de um novo método capaz de determinar actividade de CES em condições 
mais próximas às fisiológicas. 
Foi desenvolvido um método espectrofluorimétrico capaz de avaliar as CES em células vivas 
intactas, usando loperamida como inibidor especifico da CES2 e Bis(4-nitrophenyl) phosphate 
como inibidor total de CES, usando as linhagens celulares Caco-2, HT-29, Hep G2 e HEK-
293T. 
O método provou ser capaz de detectar CES em células vivas e diferenciar a actividade de 
CES2 de outras CES. Foram observadas diferenças entre este método e os métodos 
tradicionais com extractos celulares, sugerindo que os últimos podem não ser a melhor opção 
quando o objectivo seja a previsão do comportamento in vivo de CES. 
Palavras-chave: Carboxilesterase 2, actividade enzimática, estabilidade enzimática, método 
células vivas  
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1. Introduction 
1.1. Carboxylesterases 
 
Carboxylesterases (Ces) (EC 3.1.1.1) are enzymes of the serine hydrolase family (1) and 
members of the esterase class of proteins (2). These enzymes catalyze the conversion of 
carboxylic esters to the corresponding alcohols and carboxylic acids and are categorized as 
phase-I drug metabolizing enzymes (2). Other classes of esterases that can be mentioned are 
phosphatases, sulphatases, lipases and cholinesterases among others. 
Recently a novel nomenclature has been proposed for carboxylesterases, starting by 
differentiating human and non-human carboxylesterases with the root CES and Ces 
respectively, followed by the family number (3) and this is the rationale used in the present 
work. Thus, five families of mammalian carboxylesterases were described, including 
carboxylesterase 1 (Ces1), the major liver enzyme, carboxylesterase 2 (Ces2) mainly 
expressed in the small intestine, carboxylesterase 3 (Ces3) expressed in brain, liver and colon, 
carboxylesterase 5 (Ces5), a major urinary protein of the domestic cat also present in human 
tissues and carboxylesterase 6 (Ces6) a predicted Ces-like enzyme in the brain (3, 4).  Among 
human carboxylesterases, two major forms (CES1 and CES2) are the most studied and the 
most relevant.  
Esterases are known to be involved in the biotransformation of several ester-containing drugs 
and prodrugs such as angiotensin-converting enzyme inhibitors (temocapril, cilazapril, quinapril 
and imidapril), anti-tumor drugs (Irinotecan, also known as Camptothecin-11 (CPT-11) and 
capecitabin) and narcotics (cocaine, heroin and meperidine) (5).  
Being remarkable catalysts, due to its wide and overlapping substrate specificities, CES 
contribution to the metabolism of ester xenobiotics has been thoroughly evaluated (6). The 
possibility to metabolize a variety of compounds comes from a large and flexible binding pocket, 
facilitating multiple binding sites (7). Still, the endogenous functions of CES are not well 
established. 
While the prodrug activation function of CES promotes a pharmacological effect, these enzymes 
are also involved in detoxifying reactions, mainly by the formation of more polar, readily 
excreted products, by hydrolysis of lipophilic toxic esters to carboxylic acids (6, 8). One of the 
major applications of CES is therefore the detoxification of pyrethroid insecticides (9), but they 
are also used for accelerating the metabolism of narcotics, as cocaine and heroin (10).  
As a more recent field of study, CES applicability in cancer treatment has been evaluated, 
mainly the activation of Irinotecan (CPT-11) (11). This drug is a water-soluble, semi-synthetic 
derivative of plant alkaloid camptothecin, and is hydrolyzed by CES, producing an active 
metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), showing up to 1000 times more potency 
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as a topoisomerase I inhibitor than Irinotecan (12). Although hydrolyzed by various CES, it was 
shown that CES2 has a 64-fold higher catalytic efficiency (Kcat/Km) for CPT-11 than CES1 (11).  
Taking into account the expression of each CES in different organisms, each tissue present 
different functions, with mammalian liver being responsible for detoxification due to a higher 
expression of CES1, and mammalian intestine, with higher expression of CES2, being involved 
in the first-pass clearance of several drugs (3, 5).  
Depending on the species, CES may exist in different relative levels and be secreted or 
exclusively intracellular.  In several species such as mouse, rat, rabbit, horse and cat (3, 4), 
both forms exist but it has been demonstrated that human CES are not found freely in the 
plasma (13).  
The exclusive intracellular location of human CES1 and 2 is due to the existence of a C-terminal 
retention sequence which enables the anchoring of CES in the Endoplasmatic Reticulum (ER) 
luminal site (3, 4). This limits the use of human serum for studies of carboxylic ester hydrolysis, 
contrary to what happens with butyrylcholine esters, for example. 
In addition, interspecies differences also pose limitations to the use of preclinical animals for 
evaluation of the pharmacokinetics of carboxylic acid esters and extrapolating to humans.  
Among human carboxylesterases, only CES1 tertiary structure has been confirmed (7, 14), 
revealing a α/β-hydrolase-fold, typical of serine esterases, but also containing a large substrate 
binding area with both rigid and flexible pockets (14). CES1 is found in trimers formed by 
approximately 60 kDa monomers. It can also be found as hexamers, formed by two trimers 
stacked together (7). 
Human CES2 is described as a much more unstable than CES1, 60 kDa protein (1) with only 
48% sequence homology with CES1 (15)  but a further study on this enzyme is needed such as 
its crystallographic characterization. Some homology models of CES2 have been proposed (16) 
but this protein has never been crystallized.  
Due to this lack of information on CES2, one of the focuses of the Laboratory of 
Pharmacokinetics and Biopharmaceutical Analysis of ITQB/IBET has been the production and 
purification of a recombinant human CES2 and its characterization, having already been able to 
demonstrate that CES2 is active in structural forms other than monomers. (17) 
 
1.2. Enzymatic activity 
 
 
Several methods have been developed to evaluate enzymatic activity, each one with its 
advantages and disadvantages. Nonetheless, the majority of the methods follow along time, the 
depletion of the substrate or the formation of a product resulting from an enzymatic reaction 
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involving a substrate binding to an enzyme active site and being converted into a product. The 
profiles thus obtained for different enzyme and substrate concentrations allow to determine 
kinetic parameters of the enzyme reaction (18).  
Specifically, the kinetics of an enzymatic reaction in its steady-state can be analyzed through 
the measurement of initial rates of product formation (before significant reduction of the 
substrate concentration) as a function of varying substrate concentrations and at a fixed 
enzyme amount. Calculating initial rates also overcome some possible factors that can affect 
enzymatic activity such as product inhibition, pH changes and enzymatic denaturation (18).   
A typical plot of initial rates against substrate concentrations (figure – 1.1) is described by the 
Michaelis-Menten enzymatic model from which Vmax and Km values can be obtained, being Vmax 
the maximum velocity at saturated substrate conditions and Km the substrate concentration at 
which V is half of Vmax. (19) 
Since Vmax represents the maximum rate achieved by the system, when all the enzyme is bound 
to the substrate, Km is considered as an inverse measurement of substrate’s affinity to the 
enzyme. With lower Km values, the rate of the reaction will approach Vmax more quickly, thus 
indicating a higher affinity (19) 
 
 
 
 
 
 
 
 
Figure 1.1 – Example of a velocity versus substrate concentration Michaelis-Menten plot for an enzyme 
with Vmax =80 nM min
−1
 and Km = 37 μM (19). 
 
The model equation is given by: 
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Through a linear or non-linear fit of the obtained curve, both Vmax and Km can be calculated. 
Another used kinetic parameter is Kcat, the overall catalytic rate of an enzyme and is obtained by 
dividing Vmax by the total enzyme concentration. 
Being enzymes with a broad substrate overlapping, competitive reactions are a possibility due 
to different substrates competing for the same active site of the enzyme (19). On the other 
hand, protein-protein interactions leading to alterations in enzyme activity have been less 
described.   
 
1.3. Analytical methods 
 
Depending on the goal of the reaction, different analytical methods can be used to evaluate the 
enzymatic activity. Taking into account the focus on carboxylesterases of this project, several 
instrumental methods of analysis have been used for quantification of the substrates and 
products of enzymatic reactions.  
The most traditionally used UV absorbance spectrophotometric methods, allow the 
quantification of total CES activity by measuring the absorbance of the formed product. 
Nonetheless, when absorbance overlapping occurs between substrates, products and/or 
inhibitors or other matrix components, it may be difficult to differentially quantify each specific 
CES activity in complex biological samples or enzyme mixtures (1, 20).  
Using fluorescent substrates or products, this problem may be overcome. For example, 4-
methyl-umbelliferyl acetate (4-MUBA) is a non-fluorescent substrate that is hydrolyzed to the 
fluorescent product, 4-methyl-umbelliferone (4 –MUB) (1) and therefore, selective quantification 
of the product is possible by fluorometry. In this technique, the molecules of the analyte are 
excited with radiation at a certain wavelength and emit radiation at a different wavelength (21).  
Separation techniques like chromatography or electrophoresis have the potential for reducing 
interference due to absorbance or emission overlapping, by previously separating the matrix 
components. 
Chromatographic methods have been described, such as a discontinuous High performance 
liquid chromatography (HPLC)-based assay to measure CES activity, however it´s a more 
expensive method, using more reagents and more time consuming (1).  
A capillary electrophoresis method was recently developed in this project host lab, taking the 
advantage of using inhibitors and being able to detect and distinguish CES2 activity from other 
CES in biological samples. This method overcame the limitation of substrates and products 
absorbing at the same wavelengths, and proved to be a fast and repeatable method, using 7 
times less sample than with classical spectrophotometric methods (20).  
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Techniques such as native electrophoresis followed by in-gel hydrolysis and Western Blot are 
alternatives that allow the detection of each CES. With native in-gel hydrolysis one can 
distinguish different CES in biological samples. Using Western Blots specific proteins can be 
detected using appropriate antibodies. However these methods are not quantitative (20).  
Another issue to take into account when choosing an analytical method for evaluation of 
enzyme activity is the sample preparation step. Several aspects must be considered, the most 
important being the stability of the enzyme itself, but also of substrates and products. When 
separating the enzymes from the rest of the biological matrix components, for example, several 
methodologies can be used, ranging from full purification from producing cells or tissues, to the 
separation of subcellular fractions, such as microsomes and cytosol (1). An approach on closer 
to physiological conditions was already made in the laboratory when testing the hydrolysis of 
ester drugs different animal’s serum through an electrophoretical mediated microanalysis 
method (22). 
 
1.4. In vitro-in vivo correlations 
 
The major goal of an in vitro method is trying to mimic in vivo conditions, so that the 
characteristic of the drug being tested can be predicted and correlated to what happens in vivo. 
The previously described methods allow determining CES activity from purified enzymes, 
mixtures or cellular extracts but they may not truly reflect CES activity in vivo. This is more 
important in the case of human CES because they are immobilized within the cell, bound in the 
luminal side of the ER.  The tertiary structure can be affected by contact with extraction buffers, 
or also the enzyme may suffer a change in solubility when taken out of its cell environment. 
Another aspect to take into consideration is the ability of the substrate to reach the enzyme in its 
cellular location, often protected by biological barriers with selective permeability. 
Animal experiments (in vivo, or ex vivo) can be used to better predict CES behaviour in a 
biological system, nonetheless regulatory authorities are increasingly trying to limit these 
experiments, thus surfacing a need of new in vitro methods that better predict their role in the 
human organism. 
During drug development, in vitro – in vivo correlations (IVIVC) are an efficient tool in order to 
cut costs and development time in the screening of potential drug candidates (23). They enable 
reducing the number of studies required for approval as well as during scale-up and post-
approval changes. (24) 
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IVIVC is defined as a predictive mathematical model describing the relationship between an in-
vitro property of a dosage form and an in-vivo response, (25) the majority being related to the 
use of cellular models to evaluate drug permeability and thus predict its in vivo absorption.  
Nonetheless, when it comes to predict CES2 metabolism with cellular models, no work is found. 
Even though several approaches are described, mainly provoking CES inhibition in the study of 
the permeability of ester drugs (26, 27), the enzymatic metabolism has not been characterized 
using cellular models.  
 
1.5. Animal cell cultures 
 
Living tissue culture initiated at the beginning of the twentieth century as a method for studying 
the behaviour of animal cells without being exposed to systemic variations that could arise in 
vivo both during normal homeostasis and under the stress of an experiment (28).   
The development of cell cultures in the 1950’s, was initially due to two branches of medical 
investigation, the production of vaccines and the study of neoplasia (28, 29).  
Through a standardization of procedures, cell lines and other technical improves such as a 
large range of different commercial culture media have made animal cell culture accessible to a 
wide range of interests (28).  
Depending on the type of assay being made, several cell lines can be chosen, the majority 
being originated from authenticated stocks of continuous cell lines and acquired from cell 
repositories such as the American Type Culture Collection (ATCC) or the Deutsche Sammlung 
von Mikroorganismen und Zellkulturen GmbH (DSMZ) (30).  
Cell lines have become a common tool in drug development for efficacy, metabolism and 
permeability evaluation of newly developed drugs but also for the production of biological drugs.  
The cell line most extensively used in in vitro permeability experiments, Caco-2, is derived from 
a human colon adenocarcinoma and when in culture, it undergoes a process of spontaneous 
differentiation leading to the formation of a cellular monolayer, expressing morphological and 
functional characteristics of the mature enterocyte (31, 32).  
This enterocyte-like cell line reaches confluency within 3-6 days and, a stationary growth after 
10 days in culture and has a differentiation period of 20-21 days, expressing many enzymes 
and transporters present in the small intestine (33). 
Although being originally a colon cell adenocarcinoma cell line, the post-confluence expressing 
properties of foetal epithelial cells may be explained as persistence of foetal or tumor-derived 
7 
 
phenotype or as incomplete conversion from the proliferative to the differentiated phenotype. 
(34) 
Nonetheless, regarding CES expression, Caco-2 phenotype differs from the small intestine one, 
with a higher CES1 and lower CES2 expression (35) and this presents a drawback of this cell 
line for modeling the fate of ester drugs. 
Also originally derived from a colon adenocarcinoma, HT-29 cellular line is a useful in vitro 
model to study cell differentiation, due to the possibility of modeling its differentiated state under 
specific culture conditions (36). It has also been used in co-cultures with Caco-2 for permeability 
studies. 
When grown in standard conditions in with glucose, present in most commercially available 
culture media, HT-29 cells grow as a multilayer of unpolarised, undifferentiated cells without 
expression of any characteristic of enterocytes (33, 37). However, when the sugar source is 
changed to galactose the cells express a moderate enterocytic differentiation (33, 37). After 10 
days in culture, cells show morphological and biochemical changes, namely cell polarization 
and changes in genes expression, indicating an epithelial differentiation (36). Although having a 
higher expression of CES2 compared to CES1, its activity is very low (39).  
Hep G2 cellular line is derived from a liver tissue with hepatocellular carcinoma, and frequently 
used in vitro as a hepatic model, being able to carry out biotransformation of xenobiotics 
compounds (40). It’s an easier to handle cell model, however with lower basal gene expression 
levels of phase I and II biotransformation enzymes, when compared with primary human 
hepatocytes (40). 
Nonetheless, both CES1 and CES2 are expressed in Hep G2 cells, as expected from a liver 
derived cell line, with predominance for CES1 (41, 42). 
To overcome the differences in CES expression between in vivo tissues and cellular cultures, 
some cellular models are improved in order to express a desired protein in higher amounts.   
In this project’s host laboratory, a CES2 transfected Caco-2 cell line was produced in order to 
present higher CES2 expression levels and improve its relevance as in vitro model, through a 
better mimicking of intestinal epithelia.   
Another cellular line, the Human Embryonic Kidney (HEK-293 T cells) was also transfected with 
human CES2 gene for protein production followed by its purification. CES2 purification was not 
easily achieved, raising questions about its stability. 
Although cellular cultures are mainly classified as ex vivo methods, being living tissues, they 
can be used as a first approach to simulate a living organism thus providing insights of in vivo 
behaviors.  
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2. Goals 
 
The main goal of the present work was to acquire insights into CES2 stability and possible 
enzyme-enzyme interactions with CES1. This was particularly relevant due to inconsistent 
results detected on the determination of enzyme activity during recombinant productions and 
also when mixtures of enzymes were analyzed.  
Starting with the premise of an eventual interaction between CES1 and CES2, several initial 
tasks were developed in order to characterize the activity of both enzymes: 
 The kinetic characterization of each isolated enzyme and calculation of the respective 
kinetic parameters (Vmax and Km) 
 Assessment of the effect of different assay conditions (media, pH, additives) in the 
enzymatic activity  
 Evaluation of the effect on activity in enzyme mixtures  
In fact it was observed that several parameters contributed to obtaining different responses in 
enzyme activity measurements which should be related both to enzyme stability/instability or 
degradation in different reaction conditions, but no evidence of in vitro enzyme interactions was 
found.  
These observations lead us to rethink the relevance of the methods that we were using for the 
study of the metabolism of ester xenobiotics, since bringing the enzymes out of their cellular 
environment was likely to introduce significant changes in their behavior.  
Taking into account the possible applications of carboxylesterases as drug metabolizers, and 
mainly prodrug activators, the development of new analytical methods able to predict its 
behavior in closer to physiological conditions becomes relevant. 
In order to face this problem and to achieve another goal of this project, the strategy consisted 
in the development of a spectrofluorometric method able to assess carboxylesterases activity in 
intact living cells, using loperamide as a specific CES2 inhibitor and bis-p-nitrophenyl phosphate 
(BNPP) as a total carboxilesterase inhibitor. 
The method was developed and successfully applied to three different adherent cell lines 
(Caco-2, HT-29 and Hep G2) and to a suspension adapted cell line, (HEK-293T), for the 
evaluation of total CES and CES2 expression.  
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3. Material and Methods 
3.1. Reagents 
 
Hog liver Ces (mostly composed by Ces1, 131 U/mg, Fluka), in house produced and purified 
CES2 (9.3 ng/µL, quantified by Bradford method), and the cells supernatant from the production 
were used in enzymatic assays. 
4-methyl-umbelliferyl acetate (4-MUBA≥ 98%,), 4-methyl-umbelliferone (4-MUB, ≥98%), 
potassium chloride (KCl, >99%), potassium di-hidrogen phosphate (KH2PO4, >99%), sodium 
chloride (NaCl, >99.5%), Ethylenediaminetetraacetic acid (EDTA, >98,5%), Triton X-100, 
loperamide hydrochloride (≥99,8%), Bis(4-nitrophenyl) phosphate (BNPP, 99%), Trizma 
Hydrochloride (>99%), Trizma Base (>99,9%), Bradford Reagent, bovine serum albumin (BSA), 
Minimum Essential Medium (MEM), dimethyl sulfoxide (DMSO, ≥99,9%) and procaine 
hydrochloride (≥97%) were purchased from Sigma-Aldrich (St. Louis, U.S.A.). 
Cells culture media and supplements, as Dulbecco’s Modified Eagle’s Medium (DMEM), MEM 
non essential amino acid (MEM NEAA), RPMI 1640, Trypsin-EDTA 0.25%, Trypan Blue 0.4%, 
penicillin-streptomycin (PenStrep), Hanks Balanced Salt Solution (HBSS), fetal bovine serum 
(FBS), phosphate buffered saline (PBS), FreeStyle™ 293, Geneticin and Pluronic F-68 were 
purchased from Invitrogen (Gibco ®, Grand Island, U.S.A.). 
CellTiter 96® AQueous One Solution Cell Proliferation Assay was obtained from Promega (San 
Luis Obispo, CA, USA).  
Mammalian Extraction Reagent (M-PER) was obtained from Pierce Biotechnology, Rockford, 
U.S.A.) 
 
3.2. Enzymatic activity assays 
 
Carboxylesterase activity was determined in cell supernatant or purified enzyme solutions 
following the hydrolysis of 4-methyl-umbelliferyl acetate to 4-methyl-umbelliferone which 
concentration was determined either by spectrophotometry or spectrofluorometry. 
Daily, a substrate (4-MUBA) stock solution was prepared by dissolving 16.36 mg in 5 ml DMSO 
to afford a concentration of 15 mM. This solution was further diluted in a 1:1 mixture of DMSO 
and phosphate buffer (90 mM KH2PO4, 40 mM KCl, pH 7.4) to the desired concentration.  
The same procedure was used to prepare a 15 mM 4-MUB stock solution (13.21 mg in 5 ml of 
DMSO). Diluted solutions were used for preparation of the calibration curves in all assays.  
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For assays followed by spectrophotometry, mostly those for evaluation of enzyme kinetics, the 
reaction buffer, blanks and samples were added to 96 wells microplates on ice, and the 
substrate was added immediately before reading to a final reaction volume of 250 µL in different 
concentrations according to each assay. The reaction was followed at 37ºC during 15 minutes 
with readings at 350 nm every 30 seconds (SPECTRAmax™340, Molecular Devices, 
Sunnyvale, U.S.A.). Calibration curves in the range of 7.5 to 500 µM 4-MUB were applied in 
every assay. 
For assays followed by spectrofluorometry, 4-MUB concentrations were determined using a 
microplate fluorescence reader (FL800 Bio-Tek Instruments, Winooski, VT, USA) with emission 
and excitation filters at 350 and 450 nm for 15 minutes every 50 seconds, at 37ºC. The range of 
the 4-MUB calibration curves were from 0.5 to 75 µM.  
All assays were performed in triplicate and in all cases reaction blanks were added and 
subtracted from reaction readings. The concentrations of the product of the reaction, 4-MUB, 
were determined by linear regression, using the calibration curve. Michaelis-Menten kinetic 
parameters (Vmax, Km and Kcat) were determined by non-linear regression using GraphPad Prism 
® 5 software. 
For the evaluation of buffer effect on the enzymatic activity, different buffer, proprietary and in-
house prepared, were used, namely phosphate buffer pH 8, 7.4, 6.5 and 5.8, FreeStyle, Tris 
and DMEM. 
Spectrophotometry assays were conducted with 80 ng of purified CES2 or 80 µL of CES2 
supernatant using 0.5 mM of 4-MUBA, while spectrofluorometric assays were performed with 10 
ng of hog liver ces and 4-MUBA concentrations ranging from 0.15 to 75 µM. CES2 supernatant 
was also tested at different concentrations as described in section 4.  
To evaluate CES1 and 2 interactions different amounts of hog liver Ces and of CES2 
supernatant were tested isolated and in the presence of each other by spectrophotometry or 
spectrofluorometry as described in section 3. 
For the evaluation of the significance of the differences between the average triplicates of 
concentrations of 4-MUB, a t-test of the mean was performed as described below.  
For each pair of averages under comparison, testing value TV is calculated and compared with 
the threshold value obtained from a t-table (of from Excel): (43) 
     
     
  
 | X  
      
     
 
Where Sd =  
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And decision is made by: 
TV ≤ t(f, P = 95%): random difference 
                      t(f, P = 95%) < TV ≤ t(f, P = 99%): probable difference 
     TV > t(f, P = 99%): significant difference 
 
 
 
3.3. Cell manipulation 
3.3.1. Caco-2 
 
Human colon carcinoma Caco-2 cells originally purchased from Deutsche Sammlung von 
Mikroorganismen und Zellkulturen (DSMZ, Braunschweig, Germany), were thawed from a 
laboratory created bank and grown in RPMI 1640 supplemented with 10% of FBS, 2mM of 
glutamine and 5000U of PenStrep. 
These adherent cells were cultured in T-Flasks with 25 and 75 cm
2 
and split three times per 
week after reaching 70-80% confluence, using Trypsin-EDTA 0.25% to detach the cells. They 
were maintained under a 5% CO2 and 37ºC environment. 
A Caco-2 CES2 transfected population was also tested. The original line was from American 
Type Culture Collection (ATCC, USA) and it was grown in DMEM medium supplemented with 0.1 
mM of MEM NEAA, 10% FBS and 0.95 mg/ml of Geneticin in 25 and 75 cm
2
 T-flasks with the 
medium being replaced every two days. They were maintained under a 7.5% CO2 and 37ºC 
environment. 
For tests of the selective pressure effect of procaine, these cells were also grown in the same 
culture medium, supplemented with procaine in concentrations ranging 500 to 1000 µM for one 
week, prior to being seeded and let to differentiate also in the presence and absence of 
procaine. 
3.3.2. HT-29 
 
The HT-29 human colon cancer cell line, originally purchased from ATCC was thawed from a 
laboratory created bank, grown and split in T-Flasks, using as culture medium RPMI 1640 
supplemented with 10% of FBS and 2 mM of glutamine. 
Before seeding, the culture medium was changed from RPMI 1640 to RPMI 1640 with 
glutamine and without glucose, and it was supplemented with 10% FBS and 5 mM Galactose 
(RPMI Gal) to induce differentiation. 
These cells were seeded in 100 µL RPMI Gal into 96 well plates, and followed the same 
procedure as Caco-2 cells, with replacement of culture medium three times a week, during the 
21 days period of differentiation. 
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3.3.3. Hep G2 
 
Derived from a Hepatocellular carcinoma, these adherent cells were originally purchased from 
ATCC and also thawed from a laboratory created bank. The cell line was grown in Minimum 
Essential Medium Eagle supplemented with 10% FBS, 2mM of glutamine, 1mM Sodium 
Pyruvate and 0,1mM Non Essential Aminoacids in 25 and 75 cm
2
 T-Flasks. 
3.3.4. Transfected HEK-293T 
 
Human Embryonic Kidney 293 cells from ATCC. The in-house suspension adapted and CES2 
transfected (geneID 8824) HEK-293T cells were used for evaluation of CES2 activity in 
comparison with non transfected HEK-293T cells. 
A pellet of an in-house production of these cells was received and immediately ressuspendend 
in HBSS buffer, counted to calculate cell concentration and activity tests performed 
immediately.  
3.4. Whole living cells spectrofluorometric method for enzymatic 
activity 
 
For the whole living cell method, Caco-2 cells were seeded at a concentration of 1.04 x 10
4 
cells/cm
2
 in 96 well plates with 100 µL of culture medium being replaced with the same volume 
of fresh medium three times a week during the 21 days differentiation period. 
For tests with HT-29 cells were seeded at 3.2 x 10
4
 cells/cm
2
.  
For both Caco-2 and HT-29 cells, 4 assays were performed to evaluate living cell’s ces activity 
towards 4-MUBA during the 21 days differentiation period. The assay is carried out by removing 
the culture medium and adding 250 µL of buffer or 25 µM loperamide or 500 µM of BNPP. After 
a 10 minutes incubation period, 250 µL of 0.05 mM 4-MUBA is added. Every solution is 
prepared in HBSS. The plate is taken to the microplate fluorescence reader and the reaction is 
followed for 15 minutes at 37ºC. Alternatively, the reaction is stopped at a specific time by 
removing the reaction solutions and transferring it to another microplate where is then 
measured the fluorescence.  
A cell extract from the cells not taken to the plate reader was produced by lysing with a lysis 
buffer containing Triton X 100 2%, EDTA 5mM, NaCl 0.25 mM and Tris HCl 50 mM followed by 
a 10 minute centrifugation (Avanti J-26 XPI, Beckman Coulter, USA) at 10000 rpm at 4ºC. The 
extracts were immediately stored at - 20ºC. The activity of these extracts was also tested in a 15 
minute reaction.  
 
15 
 
For the Hep G2, seeds were of 6 x 10
5
 cells/ml  and only one assay was performed 24 hour 
after seeding where cells had already adhered. Both whole living cells, and extracts prepared as 
described above, were tested. 
CES2 transfected HEK 293T and non-transfected cells were also tested. This is a suspension 
adapted cell line and therefore slight differences relative to the previous assays where applied. 
Namely, no delay was necessary for adherence as in the case of HepG2. Different volumes (25, 
20 and 15 µL) of cells suspension were tested in the presence and absence of inhibitors as 
described previously, with 0.05 mM of 4-MUBA, 25 µM loperamide and 500 µM of BNPP. 
Extracts of both transfected and non transfected cells were prepared by lysing with M-PER 
buffer and centrifuged for 10 minute at 10000rpm and 4ºC, and the resulting extracts were 
analyzed as described previously using in each assay an amount equivalent to that used in the 
whole living cell method. 
 
3.5. Measurement of cell concentration and viability 
 
The Trypan Blue exclusion method was used to determine cell concentration in each culture. 
The cells were detached from the T-Flasks or plate wells with Trypsin-EDTA 0.25% and added 
to a 0.1% (v/v) Trypan blue solution diluted in PBS and counted in a Fuchs-Rosenthal 
haemacytometer (Brand, Wertheim, Germany). 
A CES2 transfected Caco-2 cell growth assay was performed in the presence of different 
concentrations of procaine. Cells were counted in the supernatant and among the adherent 
ones, in duplicate every day for 11 days. 
 
3.6. Citotoxicity assay 
 
4-MUBA citotoxicity towards the transfected Caco-2 cells was tested using the CellTiter 96® 
AQueous One Solution Cell Proliferation Assay, which is composed of 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS). This compound is 
converted by viable cells into the aqueous soluble formazan, a colored compound. The quantity 
of formazan is proportional to the number of viable cells in culture and can be measured by 
absorbance at 490 nm. 
Transfected caco-2 cells were seeded at a concentration of 1.04 x 10
4 
cells/cm in a 96 well plate 
until they reached confluence. They were then incubated for 2 hours with 4-MUBA in 
concentrations ranging from 0.025 to 0.2 mM. These solutions were prepared in the culture 
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medium, diluted from stock solutions and 200 µl were added to the assay plate. After the 
incubation period, 40 µl of the MTS solution was added to each well, following another period of 
incubation of 2 hours when finally the absorbance was measured at 490 nm using a 
SPECTRAmax™340 microplate spectrophotometer. Readings were made at the end of the 
incubation period, 120 min and also at 160 and 200 min.   
 
3.7. Protein quantification 
 
For total protein quantification, cells were firstly lysed with a lysis buffer containing Triton X 100 
2%, EDTA 5mM, NaCl 0,25mM and Tris HCl 50 mM followed by a 10 minute centrifugation at 
10000 rpm at 4ºC. The extracts were immediately stored at - 8ºC. 
The measurement was performed by the Bio-Rad Protein Assay based on the Bradford method 
(44) which determines protein concentration by adding an acidic dye to a protein solution 
followed by a measurement at 595 nm in a microplate reader. This dye-binding assay is based 
on a differential color change of a dye (Comassie Brilliant Blur G-250) in response to various 
concentrations of protein, shifting its maximum absorbance from 465 nm to 595 nm when the 
binding occurs (44). 
Following the manufacturer’s instructions, the Standard Procedure for Microtiter plates, with a 
linear range of assay of 0.05 mg/ml to approximately 0.5 mg/ml, was the used one, using BSA 
as standard. Briefly, 10 µl of each standard or sample were added to the plate wells followed by 
the addition of 200 µl of diluted dye reagent (1:4 dilution in distilled water from Concentrate Dye 
Reagent). After a, period of incubation of at least 5 minutes and no more than an hour, at room 
temperature, the plates were read in a SPECTRAmax™340 spectrophotometer at 595 nm. 
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4. Results and discussion 
4.1. Enzyme characterization 
Work was initiated by the characterization of the enzyme solutions available at the laboratory 
namely commercial hog liver ces (since mostly constituted by ces1, the two designations will be 
used interchangeably) and in-house produced recombinant human CES2. With this objective, 
the kinetic parameters of hydrolysis reaction of 4-MUBA to 4-MUB were determined and the 
effect of the composition of the reaction medium was investigated. 
 
4.1.1. Kinetic parameters 
 
Hydrolysis of 4-MUBA into 4-MUB was chosen since this substrate is more stable than the 
commonly used CES substrate p-NPA (15) and it has a higher specificity towards CES2 (1). 
The reaction buffer was phosphate buffer at physiological pH 7.3, which was previously 
described by other authors as a reaction buffer used in this reaction (15). 
 
 
 
 
A                B    
 
Figure 4.1.1 - Michaelis-Menten plots for hog liver Ces (A) and CES2 (B) obtained by non linear 
regression using Prism GraphPad5. Error bars represent the standard deviation of three independent 
measurements 
For hog liver Ces kinetics, 25 ng of enzyme were used and 4-MUBA ranged from 7.5 to 250 µM. 
For CES2 were used 50 ng of purified enzyme and 4-MUBA concentration ranged from 7.5 to 
500 µM. Quantification of 4-MUB was by spectrophotometry. 
By plotting substrate concentrations against the reaction rate, a Michaelis-Menten model of a 
kinetic reaction is observed. The used software automatically fits the values, and no evidence of 
an inadequate model was found, making it possible to calculate Vmax, Km and Kcat of both 
enzymes by a non linear fit. 
Table 4.1 presents the results of this determination using GraphPad Prism software and their 
comparison with values from the literature. 
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Table 4.1 – Determined and literature values for the kinetic parameters of the hydrolysis of 4-MUBA by 
CES2 and Ces1/CES1. Error values represent the standard deviation of three independent measurements 
 In-house  Literature 
 4-MUBA in phosphate buffer  4-MUBA in phosphate buffer 
 Vmax (µM/min) Km (µM) Kcat Km (µM) 
Hog liver Ces  
(mostly Ces1) 
8.9±0.3 
(25 ng enzyme) 
166±10 5364±162 800* 
CES2  7.1±0.3 
(50 ng enzyme) 
375±28 2117±88 150* 
*Purified Human CES1 and CES2, (15) 
 
Comparing the obtained values with described ones using the same substrate and reaction 
buffer but with a human CES1, one can say that contrary to the results of Pindel et.al. (5), the 
present results point out to a higher affinity of CES1 for 4-MUBA than CES2. 
Differences obtained may be related to the enzyme origin, purity or even the calculation 
methods. These values were calculated using 4-MUB calibration curves, however some authors 
prefer to use the molar extinction coefficient of 4-MUB (12.2 mM
-1
cm
-1
). If such approach were 
used in the present work, the result for Km would be 250 µM which illustrates an important 
source of variability of results. 
4.1.2. Effects of the reaction media in ces activity 
 
Previous evidence (46) pointed out to a significant instability of CES2 in the hydrolysis reaction 
buffer (phosphate) in comparison with the medium where the enzyme was produced 
(FreeStyle). 
In order to confirm FreeStyle stabilization ability, the hydrolysis reaction was evaluated in both 
buffers during 15 minutes at 37ºC and at five different concentrations starting at 0.32 ng/µL (80 
ng) of purified CES2 and serially diluting (1:3). 0.5 mM of 4-MUBA was used in all reactions and 
substrate and enzyme blanks in each buffer were also tested. 
Non enzymatic hydrolysis of 4-MUBA was found to be higher in FreeStyle than in phosphate 
buffer. Still, after subtracting the respective non-enzymatic hydrolysis from the total activity of 
the enzyme in each buffer, a higher hydrolysis rate was observed in FreeStyle (Figure 4.1.2) in 
comparison to phosphate buffer. This suggests that CES2 is more stable in FreeStyle 
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Figure 4.1.2 – Rate of formation of 4-MUB through the hydrolysis of 4-MUBA by different dilutions of 
purified CES2 in phosphate buffer pH 7.3 and in FreeStyle  
 
CES2 was tested again in a new assay where the effect of replacing one reaction medium by 
another was evaluated: CES2 was initially added to phosphate buffer and serial dilutions 
initiated in the same buffer. At the 2
nd
 dilution, phosphate was replaced by FreeStyle. The 
assays with a single buffer as mentioned previously were also repeated. 
For this experiment, non purified enzyme was used instead of the purified enzyme solution. This 
decision was made to make sure that the enzyme was in the best conditions possible, since it 
had been observed previously that the enzyme was much more stable before purification (in the 
cell supernatant) than in the cryopreservation medium (45).   
In this case, protein quantification of the supernatant was not possible due to interferences in 
the analytical methods and thus whenever using supernatant this is referred by volumes and not 
by enzyme amount. Initial amount of the enzyme solution (80 µL) was set so that similar 
hydrolysis rates were obtained in comparison with the previous experiments. 
 
Figure 4.1.3 – Comparison of CES2 activity in phosphate buffer, FreeStyle and phosphate buffer diluted to 
FreeStyle. Error bars represent the standard deviation from three independent measurements 
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As seen above (Figure 4.1.3) in the first dilution, CES2 activity was higher in FreeStyle than 
phosphate buffer, in accordance with the previous assay. Still the difference was considered to 
be random.  As the dilution rate increases the significance of the differences between FreeStyle 
and phosphate diluted samples increases. When diluted from phosphate buffer to FreeStyle, a 
recovery of the enzymatic activity is visible, with the 4-MUB formation rate approaching the 
values of FreeStyle alone and becomes significantly different from phosphate buffer alone.  
All the previously described assays were performed by following the formation of 4-MUB by 
spectrophotometry. Taking account that these effects might be concentration dependent, it was 
decided to reduce enzyme concentration. In order to do so, a different method has to be used 
since the original has not sensible enough. 
A fluorimetric method was therefore chosen due to its higher sensitivity which allows testing 
lower amounts of enzyme and/or substrates. As an indication of its sensitivity, the linearity 
range of the 4-MUB calibration curve obtained with this method was around the 0.15 to 50 µM 
range, against the 50 to 500 µM range in spectrophotometry (appendix A). 
To firstly test the method and due to reduced availability of CES2, hog liver ces (10 ng) was 
tested in phosphate buffer, FreeStyle and DMEM medium, and its kinetic parameters were 
calculated, the same manner as with spectrophotometry (Table 4.2).  
 
Table 4.2 – Determined values for the kinetic parameters of the hydrolysis of Ces1. Error values represent 
the standard deviation of three independent measurements 
 Vmax (µM/min) Km (µM) 
Phosphate buffer 
pH 7.4 
3.8±0.4 63 ±10 
FreeStyle 2.5±0.1 43±4 
DMEM 3.8±0.3 120±14 
 
Comparing these values, a difference in Km with different media is observed suggesting, as 
with CES2, different enzymatic behaviors when in different conditions. Standard deviations are 
relatively low suggesting a significant difference between these values and between these and 
that determined in a larger concentration range. However, one should bear in mind that these 
standard deviations were obtained in repeatability conditions and may not reflect the actual 
variability in these types of determinations and that may justify also some of the frequent 
discrepancies usually found in the literature. To further assess CES2 activity dependence on 
the medium used, 5 µL of CES2 supernatant was evaluated in the presence of different media 
and pH. FreeStyle, DMEM and phosphate buffer at pH 8, 7.3, 6.5 and 5.8 were tested with two 
different 4-MUBA concentrations, of 0.03 and 0.05 mM to assess the enzyme response at lower 
substrate concentrations.  
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Figure 4.1.4 – CES2 supernatant activity comparison in different buffers and at two different 4-MUBA 
concentrations 
Being an explorative assay, no replicates were made, so no definite conclusions could be 
made. Still, different activity rates were clearly visible with different media and pH. In this assay, 
it was shown that DMEM also promotes a non-enzymatic hydrolysis of 4-MUBA in the same 
way as FreeStyle. 
With this preliminary assay it was observed a proportional enzymatic response with different 
media at lower 4-MUBA concentrations. Still, linearity of the assay at the analysis 
concentrations had not been established yet at this time. Linearity was therefore evaluated 
using 0.5, 1, 2 and 4 µL of CES2 supernatant at 0.05 mM of 4-MUBA in phosphate buffer. 
As illustrated in figure 4.1.5, it was in fact possible to confirm linearity of the reaction rate in this 
enzyme concentration range. 
 
 
Figure 4.1.5 – Representation of the rate of product formation as a function of the amount (µL) of CES2 
supernatant. The error bars represent the standard deviation from three independent measurements 
22 
 
With this test, a proportionality between the amount of enzyme added and its activity was 
observed, showing that these values are in the linear response range of CES2, a necessary 
condition to perform enzymatic assays. 
With the optimal enzyme amount confirmed, a final study of the different media was carried out 
using 0.5 µL of CES2 supernatant, 0.05 mM of 4-MUBA, with phosphate buffer and a new 
buffer, Tris-HCl both at pH values of 7.3 and 8, FreeStyle and DMEM. Each assay was 
performed in triplicate.  
  
Figure 4.1.6 – CES2 activity comparison (in terms of the rate of formation of 4-MUB) in phosphate buffer 
and Tris-HCl pH 7.3 and 8, DMEM and FreeStyle. Error bars represent the standard deviation of three 
independent measurements 
 
As previously observed, CES2 showed higher activities at higher pH with both phosphate buffer 
and TRIS-HCl buffers. A probable difference was found between different pH of the same buffer 
but not between different buffers (phosphate and Tris-HCl) at the same pH thus making it 
possible to conclude that CES2 activity suffers no change with these different buffers and it’s 
positively affected by a pH increase 
FreeStyle was proven to provide higher CES2 activity, having significant differences to 
phosphate and Tris at both pH and a probable difference with DMEM.  
DMEM only showed a significant difference to pH 7.3 buffers. Having pH 7.4 and 7-7.5 
respectively, the positive effect of both DMEM and FreeStyle were not due to a pH effect. 
With these set of assays it was possible to conclude that CES2 does show different activity 
rates when in different media, and from all the tested buffers the one with the most positive 
effect is FreeStyle. Moreover this enzyme is sensitive to pH changes and has higher activities at 
higher pH. 
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Taking into consideration the fact that both FreeStyle and DMEM promote a non enzymatic 
hydrolysis of 4-MUBA, and even thought this value is subtracted from the total activity, there is a 
higher probability of introducing errors in the calculation of formed 4-MUB in these media.  
FreeStyle is a proprietary medium from Gibco, used as culture media in cellular cultures, and is 
supplemented with several compounds in order to promote cellular growth and viability. The 
exact composition is not disclosed and therefore it is not easy to evaluate if any of the additives 
of this buffer might be responsible for stabilization of the enzyme in a more active form that the 
simplest buffers (besides pH). We speculated that Pluronic-f68 should be one of these additives 
and tested it stabilizing effect in the range of 0.25 up to 1% in phosphate buffer pH 7.3, however 
no significant differences were detected between the plain and the supplemented buffer (results 
not shown).  
Although it was possible to detect higher activity rates in the commercial media and higher pH 
buffers, it’s harder to control non-enzymatic hydrolysis, therefore making the pH 7.3 phosphate 
buffer the choice for the following assays. 
 
4.1.3. Assessment of ces1 and CES2 possible interactions 
 
Faced with the possibility of a CES1 and CES2 interaction (20), this hypothesis was firstly 
tested with the spectrophotometric method.  
By applying both enzymes isolated and in the presence of each other, a comparison of the 
individual and total activity of combined enzymes can be made. Both enzymes were also 
applied together in the presence of loperamide, a CES2 inhibitor, making it possible to evaluate 
the behavior of only Ces1 (hog liver Ces is composed mostly by Ces1) when in presence of 
CES2.  
Starting with 50 ng of Ces1 and 5 µL of CES2 supernatant applied isolated and together in the 
presence of 25 µM of loperamide with a 10 minute incubation period, and 0.3 mM 4-MUBA, the 
first test showed no significant signs of interactions. Loperamide was also added to Ces1 and 
CES2 alone. 
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Figure 4.1.7 – Amount of 4-MUB formed after 8 min in the presence of isolated or of mixtures of CES2 
supernatant (5 µL) and Ces1 (50 ng). Orange bar represents the amount expected in the mixture, 
considering the product formed with the isolated enzymes. Purple bar represents the amount formed in the 
mixture by inhibition of CES2 (25 µM of loperamide). Grey bar represents the ammount formed by ces1 
with the presence of loperamide. Blue bar represents the inhibition of CES2 with loperamide.  Error bars 
represent standard deviation from three independent measurements 
 
These results show the amount of formed 4-MUB at a single point in the linear activity zone of 
the reaction. By adding the amount of 4-MUB formed by each isolated enzyme, a theoretical 
Ces1+2 total activity can be calculated, and compared to the real Ces1+2 total activity of both 
enzymes when in the presence of each other. 
No significant difference was found when comparing activities of isolated and mixed enzymes. 
Considering the Ces1+2 as the total (100%) activity, when loperamide was added to Ces1+2 its 
activity was reduced to 53%, so CES2 was responsible for 47% of the total activity, a similar 
value of the isolated CES2 activity of 50% when compared to the total Ces1+2. 
Furthermore, it was shown that ces1 activity is not inhibited by loperamide while it efficiently 
inhibits CES2. Moreover when in the presence of loperamide, the activity of the mixture is 
reduced to the level of activity of Ces1.  
To evaluate if these observations were independent of the enzyme concentration, a new set of 
assays was performed through spectrofluorometry, enabling the use of smaller amounts of 
enzyme and 4-MUBA concentrations. This method also allows the use of BNPP that can’t be 
used in spectrophotometry due to having its high absorbance at 350 nm which is the maximum 
of absorbance of 4-MUB (20). 
Two initial assays were performed, the first (figure 3.1.9 A) with 10 ng of Ces1 and 1 µL CES2 
and 0.1 mM of 4-MUBA, and the second one (figure 3.1.9 B) with 5 ng Ces1 and 0.5 µL CES2 
and 0.05 mM 4-MUBA. 
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   A      B 
Figure 4.1.8 – Amount of 4-MUB formed after 8 min in the presence of isolated or of mixtures of CES2 
supernatant (1 µL) and Ces1 (10 ng) with 0.1 mM 4-MUBA (A) and CES2 supernatant (0.5 µL) and Ces1 
(5 ng) with 0.05 mM 4-MUBA (B). Green bars represent the ammount formed by Ces1 and CES2 mixture. 
Purple bars represent the expected ammount of the mixture considering the product formed by each 
isolated enzyme.  Error bars represent standard deviation from three independent measurements 
With these first spectrofluorometric assays, even though a slight loss of activity is observed 
comparing to the theoretical total activity (8.6% and 2.4% difference in the first and second 
assay respectively), again no evidence of an interaction was found since the calculated 
differences were shown to be non-significant. 
A final test was made to conclude about the non existence of interaction with 5 ng Ces1 and 0.5 
µL CES2 and 0.05 mM 4-MUBA, and loperamide and BNPP being applied as well. 
 
Figure 4.1.9 – Isolated Amount of 4-MUB formed after 8 min in the presence of isolated or of mixtures of 
CES2 supernatant (0.5 µL) and Ces1 (5 ng) with 0.0.5 mM 4-MUBA. Green bar represent the ammount 
formed by Ces1 and CES2 mixture. Orange bar represent the expected ammount of the mixture 
considering the product formed by each isolated enzyme.  Purple bar represents the amount formed in the 
mixture by inhibition of CES2 with loperamide. Blue bar represents the inhibition of the mixture with BNPP 
(500 µM). Error bars represent standard deviation from three independent measurements 
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In accordance to all the previous assays, there was no significant difference between the 
theoretical total activity of both enzymes, and the one observed in this test, with CES2 in the 
mixture being responsible for 76% (by inhibition with loperamide) of total activity and the 
isolated CES2 activity being 67% when compared with total Ces1+2. 
 Moreover, the activity of isolated ces1 was the same as its activity when in presence of CES2 
and therefore there is no evidence that an interaction exists between Ces1 and CES2 affecting 
their activity.  
On the other hand it was possible to conclude that hydrolysis rates are strongly dependent on 
the buffer pH and composition and therefore slight differences between methods may have a 
significant impact in the results.  
The hypothesis of an interaction between both enzymes surfaced in a previous work, where a 
new capillary electrophoresis method was developed to assess carboxilesterases activity and 
an evidence of a diminished total activity when both enzymes are combined was found (24). 
Being a different analytical method with different sample preparations may explain the 
misleading conclusion from the previous work. The use of extraction buffers to prepare the 
samples might have caused the instability of CES2 and consequently its loss of activity. 
Moreover reactions were not followed in time. Instead, they were stopped at a specific time and 
then analyzed by capillary electrophoresis. Although it was assured that this time was within the 
linear range of the reaction, this may have had an impact in the determination. 
 
4.2. Whole living cells spectrofluorometric method 
 
Having concluded on the non existence of an in vitro enzymatic interaction with both 
carboxylesterases in study, and having successfully tested the hydrolytic reaction by 
spectrofluorometry, we proceeded to the development of a whole living cell method and to its 
evaluation in comparison with the more commonly used cell extraction method. 
Considering that therapeutic agents need to surpass several biological membranes before 
reaching their target, the analysis of cell extracts may be misleading since it removes potential 
barriers to drug efficacy or disposition.   
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4.2.1. Method development and optimization 
 
To firstly test the possibility of applicability of this method, a set of assays was designed using 
Caco-2 cells.  
Before starting those assays, the cytotoxic effect of 4-MUBA towards Caco-2 cells was 
evaluated to ensure an adequate choice of the substrate concentrations used in the assays.  
 
Figure 4.2.1 – Cytotoxic effect of four different 4-MUBA concentrations towards Caco-2 cells 
As seen in figure 4.2.1, a concentration of up to 0.05 mM of 4-MUBA could be used since cell 
viability remains above 80% after several hours in the presence of the compound.   
Caco-2 was chosen since it is a well studied and robust cell line. Cells from the DSMZ bank 
were grown and seeded in 96 well plates. Throughout the 21 days differentiation period, the 
hydrolytic ability of the cell monolayer was evaluated at different time points. Whenever an 
assay was made, the culture medium was removed and the cells monolayer was rinsed with 
100 µL HBSS. Since the cells are adherent to the plate wells and homogenization could disrupt 
the cells, the total assay volume of the reaction was added once, already with 4-MUBA. So a 
solution of 0.05 µM of 4-MUBA was prepared in HBSS and 250 µL were added to the cells.  
Depending on the type of assay, different procedures were used: 
The first case, when cells being used were to be discharged after the assay, the whole plate, 
containing the cells was taken out of the aseptic conditions and taken to follow the reaction 
occurring in the spectrofluorometer (this was considered an invasive test). The reaction was 
followed during 15 minutes and a kinetic profile of the hydrolytic reaction occurring due to CES 
present in Caco-2 cells was evaluated. 
If the plate was to be reused after the assay (hereafter called non-invasive test), in order to 
avoid contamination, the whole plate could not be taken out to be measured. In this case, at a 
specific time (8 minutes), the cell supernatant containing the reaction medium and the products 
was removed and transferred to another plate to be measured. This assay gives information on 
the amount of 4-MUB at a single point in the reaction that was found to still fall in the linear 
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range of the reaction. After the supernatant was removed, 100 µL of fresh culture medium was 
added to the cells so they can keep on growing.  
For assays requiring the use of inhibitors, after rinsing the cells with HBSS and prior to the 
addition of 4-MUBA, loperamide (25 µM) or BNPP (500 µM), were applied and left to incubate 
for 10 minutes at 37ºC. After the incubation period, the solutions were removed and a solution 
containing 4-MUBA and the respective inhibitor was added and the reaction started. BNPP 
concentration was chosen based on the studies of Imai et al (25), where it had been described 
as a non-toxic concentration to mammalian cells and able to inhibit 98% of specific hydrolysis 
by CES. 
Cellular extracts were also made and their activity was tested same way as living cells, in order 
to assess a possible correlation between both methods. 
Plates were prepared to contain triplicates of each assay, blanks and additional wells for cell 
count and protein quantification. 
 
Figure 4.2.2 – Schematic illustration of the whole living cells, non invasive and cell extract methods 
Results are presented after normalization for the average number of cells counted at each time 
point. 
In a preliminary assay, the results from the whole cells assay showed an expected profile (figure 
4.2.3) with an increase in the carboxylesterase activity with the differentiation time proving that 
4-MUBA is able to enter the cells and reach the Endoplasmatic Reticulum where it is hydrolyzed 
by its carboxylesterases. Only a slight, usually non-significant, decrease in activity was 
observed upon addition of loperamide, thus confirming a reduced amount of CES2 as expected 
in this cell line. In the presence of BNPP a higher inhibition was observed but a high level of 
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activity was still present revealing, either the presence of esterases other than 
carboxylesterases, or a difficulty in the diffusion of BNPP into the endoplasmatic reticulum 
where the carboxylesterases are located. This effect was not reported by Imai et al that 
routinely uses this inhibitor in permeability experiments (25).  
 
Figure 4.2.3 – Caco-2 whole living cells CES activity towards 4-MUBA (0.05 mM), in the presence and 
absence of inhibitors (BNPP 500 µM and loperamide 25 µM) and throughout the differentiation period. 
Error bars represent standard deviation from three independent measurements. 
Regarding the non-invasive method, CES total activity was analyzed at a single point (8 
minutes) and used cells were maintained in culture after the assay to be later retested. In this 
case, no inhibitors were used.  
The newly used cells activity was compared with the reused ones (figure 4.2.3 A) and it was 
observed that cells underwent 3 assays without losing activity compared to the newly used 
ones. By plotting the activity from new against reused cells a linear correlation can be obtained, 
suggesting that cells can indeed be reused several times (figure 4.2.3 B). 
   A      B 
Figure 4.2.4 – Caco-2 activity towards 4-MUBA (0.05 mM) along the differentiation period, evaluated 
through the non-invasive method. Comparison of new and re-used cells (A) activity and the respective 
correlation (B). Error bars represent the standard deviation from three independent measurements.  
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4.2.2. Caco-2 and HT-29 cells 
 
After this initial implementation the next set of assays were carried out with Caco-2 and HT-29 
cells, with the goal of comparing the extraction and the whole living cell methods in the 
characterization in different cell lines. 
CES activity was measured directly from the whole living cells, in the presence of inhibitors. As 
describe above, one plate for each cell line was also inoculated so that the activity could be 
measured by the supernatant method. These wells were not reused, instead they were lysed 
and the resulting extracts were also evaluated by the spectrofluorometric method. For each 
assay a cell count was made, and the total protein present in the extracts was quantified by the 
Bradford method, so that every assay could be normalized by cell count or protein 
concentration. 
The total CES activity was measured by the non-invasive method for both Caco-2 and HT-29 
cell lines, and compared with the invasive whole cell method, confirming the above described 
direct correlation between the two measuring methods, making it possible to re-test the exact 
same cells for total activity throughout the 21 days period. 
 
 
Figure 4.2.5 – Correlation between the non-invasive and the whole living cell methods in the determination 
of CES activity through the amount of 4-MUB produced along the differentiation period of Caco-2 (red) and 
HT-29 (blue).  
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   A       B 
Figure 4.2.6 – Caco-2 whole living cells (A) and extracts (B) CES activity towards 4-MUBA (0.05 mM), in 
the presence and absence of inhibitors (BNPP 500 µM and loperamide 25 µM) and throughout the 
differentiation period. Error bars represent standard deviation from three independent measurements. 
The results for these assays were normalized by cell count and are presented as a 4-MUB 
formation rates per cell (nmol 4-MUB cel
-1
 min
-1
).  
A higher total activity was found in the extracts. In addition, the slight increase in CES activity 
observed with living cells during cellular differentiation but was much more evident when 
analyzing cell extracts.  
Regarding the relative CES2 activity, the method was able to detect residual activities both in 
the living cells analysis and in extracts. Although a tendency for a higher activity was observed 
in the first case, neither one can be considered significant. 
 
Table 4.3 - CES relative activities in Caco-2 living cells and extracts along the differentiation period 
 
 7th 12th 18th 21st 
Living cells 
CES2 11.59 8.99 5.98 5.76 
Other CES 58.3 61.3 58.5 53.4 
Non-CES 30.1 29.7 35.5 40.8 
Extracts 
CES2 1.6 1.8 - 1 
Other CES 68 57.3 92.3 79.5 
Non-CES 30.5 41 25 19.5 
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HT-29 cells were tested in the same conditions and similar conclusions can be drawn from the 
comparison between the results obtained with the living cell method and the extract method. 
   A      B 
Figure 4.2.7 – HT-29 whole living cells (A) and extracts (B) CES activity towards 4-MUBA (0.05 mM), in 
the presence and absence of inhibitors (BNPP 500 µM and loperamide 25 µM) and throughout the 
differentiation period. Error bars represent standard deviation from three independent measurements. 
On the other hand, at the early stages of differentiation, the living cells method affords higher 
activities than the extraction method. Still a lower relative CES2 activity was observed in 
extracts, as in Caco-2.  
A higher CES2 than CES1 gene expression has been described for HT-29 cells (36). However, 
activities from each specific CES were not shown, only being described as “very low total CES 
activity”. The present results contradict those authors since relatively low amounts of CES2 
were found in comparison with other esterases (and it is unlikely those other esterases do not 
include mostly CES1). With this method, HT-29 living cells promoted a slightly superior CES2 
activity when compared to Caco-2, however still much lower than CES1. This suggests a 
mismatch between the expression and activity of CES.  
Table 4.4 - CES relative activities in HT-29 living cells and extracts along the differentiation period 
  7th 12th 18th 21st 
Living cells 
 
CES2 15.3 24 3.5 18.6 
Other CES 54.3 47.4 67.6 54.9 
Non-CES 30.5 28.6 28.9 26.5 
Extracts 
CES2 - 5.48 0.85 10.22 
Other CES 100 94.5 64.5 56.7 
Non-CES - - 34.7 33.1 
 
The lower activity in living cells may be due to the fact the along the differentiation period, 
cellular membranes become less permeable, thus making the entrance of 4-MUBA inside the 
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cells more difficult. This does not reflect a decrease in the activity along the differentiation 
period since it is compensated by the increase in CES2 expression and activity. In extracts, 
cells are disrupted and enzymes are free in solution, not having a permeability limitation, so the 
increase in total activity is more significant. 
The lower relative CES2 activity in extracts suggests that the enzyme is degraded or looses 
activity upon extraction. In fact, quite a strong lysis buffer was necessary due to the robustness 
of Caco-2 cells at the late stages of differentiation. Adding this to the fact that the extracts do 
not allow reproducing in-vivo conditions and therefore enzymatic behavior, one may speculate 
that the developed method is a better alternative when a close physiologic response is sought. 
4.2.3. Hep G2 cells – a cell line intrinsically expressing CES2 
 
As a first application of the develop method in CES2 higher expressing cell lines, the same 
methods and type of measurements were performed on Hep G2 cells. Since the cells do not 
differentiate, only one assay was done 24 hours after inoculating the plates when the cells were 
already adherent. 
In this case the results show a different profile than with Caco-2 and HT-29. This cellular line 
activity was significantly higher in living cells compared to its extracts, and the CES2 relative 
activity was not so significantly different in each case, with 31 and 28% relative CES2 activity in 
living cells and extracts respectively. 
 
Figure 4.2.8 – Hep G2 whole living cells and extract CES activity towards 4-MUBA (0.05 mM), in the 
presence and absence of inhibitors (BNPP 500 µM and loperamide 25 µM). Error bars represent standard 
deviation from three independent measurements. 
 
Being a non differentiated cell line, and with a different origin (liver hepatocellular carcinoma), its 
cell cytoplasmatic membrane permeability may be higher than that in the previous cell lines, 
explaining a higher total activity in living cells. This profile was similar to HT-29 and Caco-2 in 
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the first days. Having done only one assay, it was not possible to observe an expected growth 
in extracts activity. 
The relative CES2 activity was higher in this cell line, what is in accordance with the levels of 
expression of this enzyme, higher in liver than in colon cells (42). 
4.2.4. HEK-293T suspension adapted cells 
 
The method was then applied to CES2 transfected HEK-293T and non-transfected cells were 
used in order to verify it ability to detect the higher CES2 percentage in the transfected cells. 
Being suspended cells, the assay pre-preparation was slightly different from that of the adherent 
cell lines.  
Again, both cell extracts and living cell were tested. 
A portion of the suspended cells was lysed with M-PER buffer, centrifuged (10000 rpm, 10min, 
4ºC) and the resulting extracts were ressuspendend in HBSS buffer. For the living cell assay, 
after calculating cell concentrations, the applied volumes were of 15, 20 and 25 µL in order to 
test total cell amounts in the same order of magnitude of previous assays, namely were 17x10
3
, 
22x10
3
 and 28x10
3 
cells per well.  
BNPP or loperamide were as before added to selected wells and left to incubate for 10 minutes 
at 37ºC. 0.05 mM of 4-MUBA was added to a final volume of 250 µL and the reaction was 
followed for 15 minutes. A similar procedure was followed using equivalent amounts of the cell 
extracts instead of living cells. Both assays were made with transfected and non-transfected 
cells, in triplicate together with 4-MUBA blanks and a 4-MUB calibration curve.  
 
Figure 4.2.9 – HEK-293T transfected (CES2 +) and non-transfected (CES2 -) whole living cells CES 
activity towards 4-MUBA (0.05 mM), in the presence and absence of inhibitors (BNPP 50 µM and 
loperamide 25 µM) for three different cell amounts. Error bars represent standard deviation from three 
independent measurements. 
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As expected, the transfected cells (CES2 +) showed a clear higher CES2 percentage 
comparing to the non-transfected ones (CES2 -), with 56±10 and 14±16 % of CES2 
respectively.  
Although all the results were normalized by cell amount, a difference is observed in the first 
assay (CES2+, 27x10
3
), which is due to the fact that these cells were obtained from a different 
production batch than the other two assays and transfection efficiency may vary in each 
production. 
 
Figure 4.2.10 – HEK-293T transfected (CES2 +) and non-transfected (CES2 -) extracts CES activity 
towards 4-MUBA (0.05 mM), in the presence and absence of inhibitors (BNPP 500 µM and loperamide 25 
µM). Error bars represent standard deviation from three independent measurements. 
Looking at the extracts, relative CES2 amount is much lower than in living cells. These relative 
CES2 results are in accordance with the described during the method optimization, suggesting 
once again a trend for an apparent higher relative CES2 activity in living cells method 
comparing to the cell extracts method.  
Regarding the total activity, it was also lower than with living cells, the same happening with 
Hep G2 cells only. Being, both HEK-293T and Hep G2, non-differentiated cell lines, this may 
suggest a pattern, where total activity is lower in the extracts of undifferentiated cells, explained 
by the lower permeability of these cells.  
 
4.2.5. The effect of substrate selection pressure on the maintenance of 
CES2 expression upon passages 
 
The possibility of a selective pressure induced by a specific CES2 substrate in enzyme 
expression and stability was tested. For this, in-house CES2 transfected Caco-2 cells (from 
ATCC) were cultured and passed 2 times in the presence and absence of procaine (500 and 
1000 µM). The cells were then and seeded at 1.04 x 10
4
 cells/cm
2 
and left to differentiate also 
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with and without procaine added to the culture medium. At the 21
st
 day after seeding CES 
activity was measured directly from the differentiated monolayer in the presence of loperamide 
or BNPP, in order to compare its activity when grown with and without procaine. All the assays 
were made with the respective 4-MUBA blanks, 4-MUB calibration curve and in triplicates. 
 
Figure 4.2.11 – Transfected Caco-2 living cells CES activity towards 4-MUBA (0.05 mM), in the presence 
and absence of inhibitors (BNPP 500 µM and loperamide 25 µM) without and with procaine (500 and 1000 
µM) at the 21
st
 day post-seeding. Error bars represent standard deviation from three independent 
measurements. 
This test does suggest a positive effect in CES2 activity when cells are grown with procaine. 
Cells grown without procaine had 28% of relative CES2 activity, and the ones grown in 500 and 
1000 µM showed a 39 and 52% CES2 activity respectively, pointing in the direction of a 
substrate induced positive pressure. Nevertheless results were shown to be non-significant. 
Although an increase in CES2 activity was observed, a diminished total activity was shown, 
suggesting a toxic effect of procaine towards the cells. To investigate the reason of this loss of 
activity a cellular growth assay was performed with cells inoculated without and with 500, 1000 
and 2000 µM of procaine. 
Cells were counted in both the supernatant and the adherent ones. Few living or death cells 
were found in the supernatant compared to the adherent ones. Moreover, counted cells in 
supernatant did not differ with different procaine concentration, meaning that procaine does not 
affect the adhesion of cells to the wells. 
Regarding the adherent cells, very few dead cells were visible (viability was always above 91.7, 
92.6, 90.9 and 80% for 0, 500, 1000 and 2000 µM respectively) showing that procaine does not 
have a cytotoxic effect towards Caco-2 cells either at the used concentrations, suggesting a 
toxic effect only with the highest concentration.  
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Instead of causing cellular death, as seen below (figure 4.2.12) the observed effect seemed to 
be related to the inhibition of cell division at higher concentrations. 
 
Figure 4.2.12 – Transfected Caco-2 cells growth assay without and with procaine (500, 1000 and 2000 
µM). Each point represents an average of two living cells count, made every day for 11 days.  
 
A citotoxic assay with several procaine concentrations, similar to the 4-MUBA described above, 
should be made in the future in order to clearly evaluate its effect.  
Still, the results of the relative expression of CES2 upon growing in the presence of different 
concentrations of procaine, being normalized by cell count, are suggestive of a positive effect of 
substrate pressure on CES2 relative activity.  
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5. Final remarks 
 
Having the enzymatic characterization as a first task of this project, both Ces1 and CES2 kinetic 
parameters were calculated following the hydrolysis of 4-MUBA to 4-MUB by 
spectrophotometry.  When compared to other data available in literature, values in the same 
order of magnitude where obtained, despite differences that can be attributed to the origin and 
concentration of enzyme, reaction conditions and calculation methods, but also to enzyme 
stability.  
For example, CES were tested in different reaction media and pH. Although the activity rates 
were dependent of the buffer and increased with higher pH, controlling the non enzymatic 
hydrolysis was harder with these alternatives, confirming phosphate buffer pH 7.3 as the best 
choice for the following tests. 
One of the major goals of the project arose from a possibility of interaction between CES1 and 
CES2 as detected in previous work developed at the host laboratory. Both enzymes were tested 
in different amounts and substrate concentrations by spectrophotometry and spectrofluorometry 
using of loperamide and BNPP as inhibitors, but no evidence of interaction was found. One may 
speculate that the instability of CES2 in different buffers and methods used might have been 
responsible for those misleading previous conclusions.  
Such instability in addition to the extremely low resemblance of the conditions of this assay to 
the in vivo conditions, pointed out to the need to test the enzyme in more physiologically 
resembling conditions, and this consisted in the second main task of the project. We have 
therefore developed a spectrofluorometric method using whole living cells, and compared it with 
the original cell extract method.  
Using Caco-2 and HT-29 cells, the new method was proven to be more sensitive to low 
amounts of CES2 as it avoids extreme measures for preventing CES2 degradation, such as 
immediate analysis of extracts, which cannot be refrigerated and need to be analyzed 
immediately; still, so need living cells... 
The fluorimetric method provided the possibility to directly read the activity from living cells, 
since it bypasses the spectrophotometry limitation regarding the cell’s optical density, which 
would interfere in the assays. Moreover, with this fluorometry, BNPP can be used and more 
information about CES activity is obtained. 
Being a non-destructive method, the possibility of reuse of the exact same cells for reanalysis 
along time, points out to the possibility of achieving higher precision with the whole living cell 
method. 
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A comparison of the methods at different stages of differentiation confirm the importance of 
membrane permeability in the in vivo hydrolysis rates, which might be extremely important when 
correlation to physiological response is sought.  
Application to CES2 transfected and non-transfected HEK-293T cells, demonstrated that the 
method was able to detect and quantify different CES2 activity levels with a tendency for higher 
sensitivity that that obtained with the cell extract method.  
The whole living cell method was also applied to evaluate the effect of a specific CES2 
substrate (procaine) in the maintenance of CES2 expression during passage and differentiation. 
Despite showing a growth inhibition effect, results suggested a positive effect of procaine in the 
maintenance of CES2 activity. Still further studies are suggested to confirm these observations, 
namely involving a more toxic substrate with a non toxic product. This should be tested at a 
concentration near the toxic limit so that only cells able to dispose of the substrate could 
survive. 
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6. Future work 
 
In parallel to the work developed for this thesis, studies were developed in the host 
laboratory for improving purification yield of CES2 from HEK-293T production. Those 
studies demonstrated that several purification conditions and additives where able to 
provide for a better yield. The thermofluor technique, which could not have been used 
before due to the reduced amount of enzyme available, confirmed then that the new 
purification buffer was determinant for enzyme stability in solution. Based on this 
knowledge, new tests can now be performed using new conditions for the preparation of cell 
extracts and improving their stability. 
 
As a concluding test on the hypothesized enzyme-enzyme interactions between CES1 and 
CES2, Biacore technique could be a useful tool to study the eventual biomolecular 
interactions in real time. For the same reason as explained above, this technique was not 
performed during this thesis. 
 
To further optimize the developed living cells spectrofluorometric method and to 
characterize each cell line, Western Blots analysis on the cellular extracts should be 
performed in order to quantify CES2 expression and correlate it to its enzymatic activity. A 
study on 4-MUBA permeability should also be done to evaluate if indeed it’s a limiting step 
in its metabolization by living cells CES.  
 
Having the new developed whole living cell method, another possible future application is in 
the characterization of CES activity in human tissues such as in liver. An interesting 
application would be in the characterization of CES2 activity in healthy and in neoplasic 
tissue, as this may be relevant for establishing personalized chemotherapy.  
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Appendixes 
 
Appendix A – Calibration curves 
 
Figure A.1 – Spectrophotometric calibration curve of 4-MUB: representation of the absorbance 
values as a function of different concentrations (µM) of 4-MUB 
 
 
Figure A.2 – Spectrofluorometric calibration curve of 4-MUB: representation of the fluorescence 
units as a function of different concentrations (µM) of 4-MUB 
 
